Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Laurus Labs Community
NSEI:LAURUSLABS Community
1
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Create a narrative
Laurus Labs
Latest
Undervalued
Overvalued
Community Investing Ideas
Laurus Labs
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Advanced Bio Catalysis And Flow Chemistry Will Strengthen Clinical Pipeline
Key Takeaways Advanced technology platforms and manufacturing expansion are set to secure growth with Big Pharma, enhancing revenue and net margins. Diversification from ARV reliance and investment in enzyme engineering are strategic moves projected to drive revenue growth and improve margins.
View narrative
₹564.93
FV
20.4% overvalued
intrinsic discount
13.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
12 days ago
author updated this narrative
Your Valuation for
LAURUSLABS
LAURUSLABS
Laurus Labs
Your Fair Value
₹
Current Price
₹680.25
3.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
100b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹99.8b
Earnings ₹6.4b
Advanced
Set Fair Value